FDA Approves First Drug for Type 3 Gaucher Disease

Author profile image Aggregator
0 comments
The US FDA on Wednesday approved Sanofi's oral drug venglustat, the first treatment approved for a type of rare genetic โ condition affecting the brain and nervous...
Reuters Health Information

Source: Medscape Neurology Published 18 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article